Bank of America’s Aerie Pharmaceuticals AERI Stock Holding History

Bank of America’s Portfolio AERI Stock Details AERI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-297,500	Closed	-$16.1M	–	7411
2018 Q1	$16.1M	Buy	+297,500	New	+$16.6M	﹤0.01%	1968
2015 Q3	–	Sell	-5,400	Closed	-$95K	–	7490
2015 Q2	$95K	Buy	+5,400	New	+$99K	﹤0.01%	5616

Bank of America's AERI Position: Q4 2022 in Review

Bank of America sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 1,081,133 shares — an estimated $16.4M sold.

Bank of America first reported a position in AERI in Q4 2013 and held it in 35 quarters. The position peaked at $47.5M in Q1 2021. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.

Bank of America reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
Bank of America sold 1,081,133 Aerie Pharmaceuticals shares in Q4 2022, an estimated $16.4M.
Bank of America first reported a position in Aerie Pharmaceuticals in Q4 2013 and held it in 35 quarters.
Bank of America's Aerie Pharmaceuticals position peaked at $47.5M in Q1 2021.
0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.

Based on Bank of America's 13F filing for Q4 2022, filed 10 Feb 2023.